spacer
spacer
Go to PDB code: 
protein links
Membrane protein PDB id
1xu0
Jmol
Contents
Protein chain
102 a.a. *
* Residue conservation analysis
PDB id:
1xu0
Name: Membrane protein
Title: Solution structure of xenopus leavis prion protein
Structure: Prion protein. Chain: a. Fragment: globular domain(residues 98-226). Synonym: xlprp. Engineered: yes
Source: Xenopus laevis. African clawed frog. Organism_taxid: 8355. Gene: prnp. Expressed in: escherichia coli bl21. Expression_system_taxid: 511693.
NMR struc: 20 models
Authors: D.R.Perez,K.Wuthrich
Key ref:
L.Calzolai et al. (2005). Prion protein NMR structures of chickens, turtles, and frogs. Proc Natl Acad Sci U S A, 102, 651-655. PubMed id: 15647366 DOI: 10.1073/pnas.0408939102
Date:
25-Oct-04     Release date:   04-Jan-05    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
Q5S1W7  (Q5S1W7_XENLA) -  Major prion protein (Fragment)
Seq:
Struc:
171 a.a.
102 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Gene Ontology (GO) functional annotation 
  GO annot!
  Cellular component     membrane   1 term 
  Biological process     protein homooligomerization   1 term 

 

 
DOI no: 10.1073/pnas.0408939102 Proc Natl Acad Sci U S A 102:651-655 (2005)
PubMed id: 15647366  
 
 
Prion protein NMR structures of chickens, turtles, and frogs.
L.Calzolai, D.A.Lysek, D.R.Pérez, P.Güntert, K.Wüthrich.
 
  ABSTRACT  
 
The NMR structures of the recombinant prion proteins from chicken (Gallus gallus; chPrP), the red-eared slider turtle (Trachemys scripta; tPrP), and the African clawed frog (Xenopus laevis; xlPrP) are presented. The amino acid sequences of these prion proteins show approximately 30% identity with mammalian prion proteins. All three species form the same molecular architecture as mammalian PrPC, with a long, flexibly disordered tail attached to the N-terminal end of a globular domain. The globular domain in chPrP and tPrP contains three alpha-helices, one short 3(10)-helix, and a short antiparallel beta-sheet. In xlPrP, the globular domain includes three alpha-helices and a somewhat longer beta-sheet than in the other species. The spatial arrangement of these regular secondary structures coincides closely with that of the globular domain in mammalian prion proteins. Based on the low sequence identity to mammalian PrPs, comparison of chPrP, tPrP, and xlPrP with mammalian PrPC structures is used to identify a set of essential amino acid positions for the preservation of the same PrPC fold in birds, reptiles, amphibians, and mammals. There are additional conserved residues without apparent structural roles, which are of interest for the ongoing search for physiological functions of PrPC in healthy organisms.
 
  Selected figure(s)  
 
Figure 1.
Fig. 1. Sequence alignment of hPrP, chPrP, tPrP, and xlPrP, where hPrP represents "mammalian-type PrP." At the top is the residue numbering for hPrP, which is used throughout this manuscript, i.e., insertions and deletions in chPrP, tPrP, and xlPrP required for maximal coincidence with hPrP are not consecutively numbered. In this alignment, the amino acids shown in red are identical in all four PrPs, and the ones displayed in blue are identical in chPrP, tPrP, and hPrP. The black box identifies the segment containing polypeptide repeats (see text) for which no individual alignments were attempted. The GPI attachment site is identified with a green box, and the glycosylation sites (asparagine attachment site and nearest-next threonine/serine) is identified with light blue boxes. The orange boxes indicate segments with higher than average sequence conservation that do not have an apparent stabilizing role in the PrP fold, and might thus be conserved for functional reasons. These include the polypeptide segment 23-42 with the N-terminal signaling-peptide cleavage site, which has been suggested to be the signaling-peptide for reinternalization of PrP (36), a Src homology 3 (SH3)-binding motif of residues 100-110 (37, 38), the segment 113-128 representing a predicted transmembrane helix (39, 40), and the segment 146-155 in hPrP, chPrP, and tPrP that shows similarity to the laminin 2-chain (see text). The pink boxes indicate segments with high amino acid identity that appear to be needed for the stability of the "PrP-fold" (see text). At the bottom, the regular secondary structures in the globular domain of the four proteins are indicated. The sequence alignment was performed interactively so as to align a maximal number of identical residues. For the globular domain (121-230), the alignment was also based on visual inspection of the three-dimensional structures. In chPrP, the insertion at the end of helix 2 was divided into two segments to properly align the glycosylation site 197-199.
Figure 2.
Fig. 2. NMR structures of the globular domains of hPrP, chPrP, tPrP, and xlPrP. The polypeptide backbone fold for the residues 126-230 (see Fig. 1 for the sequence numbering used) and the core side chains with <20% solvent accessibility are shown for each species, as a superposition of the 20 conformers used to represent the NMR structure. The following side chains are included (see Fig. 1 for the sequence information): 141, 149 (only for chPrP and xlPrP), 150 (only for hPrP and xlPrP), 161, 162, 164 (only for xlPrP), 175, 176, 179, 180 (only for hPrP, chPrP, and tPrP), 183, 184, 205, 206, 209, 210, 213, 214, and 218. (A) hPrP (side chains shown in pink). (B) chPrP (side chains shown in blue). (C) tPrP (side chains shown in green). (D) xlPrP (side chains shown in yellow).
 
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
21390367 D.R.Brown (2011).
Prions and manganese: A maddening beast.
  Metallomics, 3, 229-238.  
20337594 C.A.Tabrett, C.F.Harrison, B.Schmidt, S.A.Bellingham, T.Hardy, Y.H.Sanejouand, A.F.Hill, and P.J.Hogg (2010).
Changing the solvent accessibility of the prion protein disulfide bond markedly influences its trafficking and effect on cell function.
  Biochem J, 428, 169-182.  
20060302 H.F.Ji, and H.Y.Zhang (2010).
beta-sheet constitution of prion proteins.
  Trends Biochem Sci, 35, 129-134.  
20458726 J.Kumar, S.Sreeramulu, T.L.Schmidt, C.Richter, J.Vonck, A.Heckel, C.Glaubitz, and H.Schwalbe (2010).
Prion protein amyloid formation involves structural rearrangements in the C-terminal domain.
  Chembiochem, 11, 1208-1213.  
20213200 V.Cecarini, L.Bonfili, M.Cuccioloni, M.Mozzicafreddo, M.Angeletti, and A.M.Eleuteri (2010).
The relationship between the 20S proteasomes and prion-mediated neurodegenerations: potential therapeutic opportunities.
  Apoptosis, 15, 1322-1335.  
20453937 W.C.Guest, N.R.Cashman, and S.S.Plotkin (2010).
Electrostatics in the stability and misfolding of the prion protein: salt bridges, self energy, and solvation.
  Biochem Cell Biol, 88, 371-381.  
19492390 A.Pietropaolo, L.Muccioli, C.Zannoni, and E.Rizzarelli (2009).
Conformational preferences of the full chicken prion protein in solution and its differences with respect to mammals.
  Chemphyschem, 10, 1500-1510.  
19173221 D.B.O'Sullivan, C.E.Jones, S.R.Abdelraheim, M.W.Brazier, H.Toms, D.R.Brown, and J.H.Viles (2009).
Dynamics of a truncated prion protein, PrP(113-231), from (15)N NMR relaxation: order parameters calculated and slow conformational fluctuations localized to a distinct region.
  Protein Sci, 18, 410-423.  
19784368 G.Schmitt-Ulms, S.Ehsani, J.C.Watts, D.Westaway, and H.Wille (2009).
Evolutionary descent of prion genes from the ZIP family of metal ion transporters.
  PLoS One, 4, e7208.  
19157856 R.A.Moore, L.M.Taubner, and S.A.Priola (2009).
Prion protein misfolding and disease.
  Curr Opin Struct Biol, 19, 14-22.  
18483857 R.C.Wiggins (2009).
Prion stability and infectivity in the environment.
  Neurochem Res, 34, 158-168.  
19618915 S.H.Bae, G.Legname, A.Serban, S.B.Prusiner, P.E.Wright, and H.J.Dyson (2009).
Prion proteins with pathogenic and protective mutations show similar structure and dynamics.
  Biochemistry, 48, 8120-8128.  
19348007 S.Hornemann, B.Christen, C.von Schroetter, D.R.Pérez, and K.Wüthrich (2009).
Prion protein library of recombinant constructs for structural biology.
  FEBS J, 276, 2359-2367.  
17879347 A.Pietropaolo, L.Muccioli, R.Berardi, and C.Zannoni (2008).
A chirality index for investigating protein secondary structures and their time evolution.
  Proteins, 70, 667-677.  
18381058 C.J.Sigurdson (2008).
A prion disease of cervids: chronic wasting disease.
  Vet Res, 39, 41.  
18778855 J.Shearer, P.Soh, and S.Lentz (2008).
Both Met(109) and Met(112) are utilized for Cu(II) coordination by the amyloidogenic fragment of the human prion protein at physiological pH.
  J Inorg Biochem, 102, 2103-2113.  
18563793 L.Ronga, P.Palladino, G.Saviano, T.Tancredi, E.Benedetti, R.Ragone, and F.Rossi (2008).
Structural characterization of a neurotoxic threonine-rich peptide corresponding to the human prion protein alpha 2-helical 180-195 segment, and comparison with full-length alpha 2-helix-derived peptides.
  J Pept Sci, 14, 1096-1102.  
  19164918 A.D.Steele, S.Lindquist, and A.Aguzzi (2007).
The prion protein knockout mouse: a phenotype under challenge.
  Prion, 1, 83-93.  
17483173 A.De Simone, A.Zagari, and P.Derreumaux (2007).
Structural and hydration properties of the partially unfolded states of the prion protein.
  Biophys J, 93, 1284-1292.  
  19164911 A.Pastore, and A.Zagari (2007).
A structural overview of the vertebrate prion proteins.
  Prion, 1, 185-197.  
17397138 C.W.Lennon, H.D.Cox, S.P.Hennelly, S.J.Chelmo, and M.A.McGuirl (2007).
Probing structural differences in prion protein isoforms by tyrosine nitration.
  Biochemistry, 46, 4850-4860.  
17419063 H.F.Ji, H.Y.Zhang, and L.L.Chen (2007).
Why are prion diseases precluded by non-mammals?
  Trends Biochem Sci, 32, 206.  
18274605 L.Ronga, P.Palladino, G.Saviano, T.Tancredi, E.Benedetti, R.Ragone, and F.Rossi (2007).
NMR structure and CD titration with metal cations of human prion alpha2-helix-related peptides.
  Bioinorg Chem Appl, 0, 10720.  
17199895 M.Premzl, and V.Gamulin (2007).
Comparative genomic analysis of prion genes.
  BMC Genomics, 8, 1.  
17172295 M.S.Shamsir, and A.R.Dalby (2007).
Beta-sheet containment by flanking prolines: molecular dynamic simulations of the inhibition of beta-sheet elongation by proline residues in human prion protein.
  Biophys J, 92, 2080-2089.  
16602696 J.W.Chen, P.Romero, V.N.Uversky, and A.K.Dunker (2006).
Conservation of intrinsic disorder in protein domains and families: II. functions of conserved disorder.
  J Proteome Res, 5, 888-898.  
16776828 L.Ingrosso, B.Novoa, A.Z.Valle, F.Cardone, R.Aranguren, M.Sbriccoli, S.Bevivino, M.Iriti, Q.Liu, V.Vetrugno, M.Lu, F.Faoro, S.Ciappellano, A.Figueras, and M.Pocchiari (2006).
Scrapie infectivity is quickly cleared in tissues of orally-infected farmed fish.
  BMC Vet Res, 2, 21.  
17062011 L.Ronga, B.Tizzano, P.Palladino, R.Ragone, E.Urso, M.Maffia, M.Ruvo, E.Benedetti, and F.Rossi (2006).
The prion protein: Structural features and related toxic peptides.
  Chem Biol Drug Des, 68, 139-147.  
16907955 M.Eiden, A.Buschmann, L.Kupfer, and M.H.Groschup (2006).
Synthetic prions.
  J Vet Med B Infect Dis Vet Public Health, 53, 251-256.  
16911960 N.Piening, P.Weber, T.Högen, M.Beekes, H.Kretzschmar, and A.Giese (2006).
Photo-induced crosslinking of prion protein oligomers and prions.
  Amyloid, 13, 67-77.  
15926068 D.La Mendola, R.P.Bonomo, G.Impellizzeri, G.Maccarrone, G.Pappalardo, A.Pietropaolo, E.Rizzarelli, and V.Zito (2005).
Copper(II) complexes with chicken prion repeats: influence of proline and tyrosine residues on the coordination features.
  J Biol Inorg Chem, 10, 463-475.  
15983653 P.Stańczak, D.Valensin, P.Juszczyk, Z.Grzonka, G.Valensin, F.Bernardi, E.Molteni, E.Gaggelli, and H.Kozłowski (2005).
Fine tuning the structure of the Cu2+ complex with the prion protein chicken repeat by proline isomerization.
  Chem Commun (Camb), 0, 3298-3300.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time.